6 hours MGTX Stock Up on Upbeat Efficacy Data From Parkinson’s Disease StudyZacks
MeiraGTx stock rises 15% as gene therapy candidate betters sham treatment in Parkinson’s disease patients.
XMeiraGTx stock rises 15% as gene therapy candidate betters sham treatment in Parkinson’s disease patients.
X